Pharmaceutical Company · Gurgaon, Haryana
Zydus Lifesciences Limited (formerly Cadila Healthcare), one of India’s largest integrated healthcare companies, maintains a regional commercial office in Gurgaon, Haryana. Founded by the Patel family and headquartered in Ahmedabad, Zydus is known for innovation, being one of the first to receive emergency use authorisation for India’s indigenously developed COVID-19 vaccine ZyCoV-D. The company serves markets in the US, EU, and over 100 countries.
Zydus’s India commercial portfolio includes cardiovascular (Atorva, Stamlo), pain management (Voveran), diabetes (Glizid, Sitagliptin), dermatology, and women’s health. The company’s novel drug discovery programme has yielded Saroglitazar (Lipaglyn) — the first new chemical entity (NCE) approved by DCGI developed entirely in India. Zydus also markets consumer brands like Sugar Free, EverYuth, and Nutralite.
The Gurgaon office manages North India commercial strategy for Zydus’s multiple therapy divisions. Zydus has manufacturing facilities across India in Ahmedabad, Baddi, and internationally, with ongoing investments in biosimilars, NCE research, and vaccines. The company’s strong presence in cardiovascular and metabolic disease makes it a key player in North India’s pharmaceutical market.
Company: Zydus Lifesciences Limited
Location: Gurgaon (Gurugram), Haryana
Business Type: Pharmaceutical Manufacturer – Cardiovascular, Diabetes & Innovation
No products found.